Welcome to the e-CCO Library!

DOP66: The effect of exclusive enteral nutrition on circulating inflammatory protein levels in paediatric patients with Crohn’s Disease
Year: 2021
Source: ECCO'21 Virtual
Authors: Pidoux , M.(1);Logan , M.(1);Milling , S.(2);Ijaz , U.Z.(3);Hansen , R.(4);Russell , R.K.(5);Gerasimidis , K.(1)
Created: Wednesday, 2 June 2021, 4:12 PM
DOP67 CKD-506, a selective histone deacetylase (HDAC) 6 inhibitor, ameliorates colitis through regulation of NF-kB and AP-1 signalling pathway
Year: 2020
Source:

ECCO'20 Vienna

Authors:

J. Shin1, N. Ha1, D. Bae1, Y.J. Lee1, Y.I. Choi1, K.H. Ryu1, G.S. Youn2, J. Park2

Created: Thursday, 30 January 2020, 10:12 AM
DOP67: A transcriptional module associated with neutrophil degranulation is highly conserved across species and is a core molecular pathway of treatment resistance in ulcerative colitis
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Cozzetto, D.(1)*;Lo, J.(1);Powell, N.(1);
Created: Friday, 14 July 2023, 10:43 AM
DOP67: CKD-506, a selective histone deacetylase (HDAC) 6 inhibitor, ameliorates colitis through regulation of NF-kB and AP-1 signaling pathway
Year: 2020
Source: ECCO'20 Vienna
Authors: Jieun Shin
Created: Tuesday, 23 June 2020, 4:58 PM
Files: 1
DOP67: Comparison of the pharmacokinetics of CT-P13 between Crohn’s Disease and Ulcerative Colitis in biologic-naïve patients; a prospective multi-center observational study of the KASID
Year: 2021
Source: ECCO'21 Virtual
Authors: Kim, E.S.(1);Park, D.I.(2);Kim, H.J.(3);Lee, Y.J.(4);Koo, J.S.(5);Kim, E.S.(6);Yoon, H.(7);Lee, J.H.(8);Kim, J.W.(9);Shin, S.J.(10);Kim, H.W.(11);Kim, H.S.(12);Park, Y.S.(13);Kim, Y.S.(14);Kim, T.O.(15);Lee, J.(16);Choi, C.H.(17);Han, D.S.(18);Chun, J.(19);Kim, H.S.(20)
Created: Wednesday, 2 June 2021, 4:12 PM
DOP67: First-line infliximab is cost-effective compared to conventional treatment in paediatric Crohn’s Disease – Results from the TISKids study
Year: 2022
Source: ECCO'22
Authors: Vuijk, S.(1);Jongsma, M.(1);Hoeven, B.(1);Cozijnsen, M.(1);van Pieterson, M.(1);de Meij, T.(2);Norbruis, O.(3);Groeneweg, M.(4);Wolters, V.(5);van Wering, H.(6);Hummel, T.(7);Stapelbroek, J.(8);van der Feen, C.(9);van Rheenen, P.(10);van Wijk, M.(2);Teklenburg, S.(3);Poleij, M.(11);Escher, J.(1);de Ridder, L.(1);
Created: Friday, 11 February 2022, 3:52 PM
DOP67: Magnification endoscopy with optical chromoendoscopy for in vivo assessment of histological inflammation in patients with inflammatory bowel disease
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

E. Klenske*1, R. Atreya1, A. Hartmann2, S. Fischer1, S. Hirschmann1, S. Zundler1, M. Iacucci3, M. Neurath1, T. Rath1

Created: Friday, 22 February 2019, 9:41 AM
DOP67: Magnification endoscopy with optical chromoendoscopy for in vivo assessment of histologic inflammation in patients with inflammatory bowel disease
Year: 2019
Source: ECCO'19 Copenhagen
Authors: Entcho Klenske
Created: Tuesday, 28 May 2019, 3:32 PM
Crohn’s disease, Ulcerative colitis, colonoscopy, Mucosal healing, Chromoendoscopy, Colonoscopy, Mucosal healing, Disease activity indices, Mucosal healing
Files: 1
DOP68 Thiomyristoyl ameliorates colitis by blocking the differentiation of Th17 cells via STAT3/IL-6 signal pathway
Year: 2020
Source:

ECCO'20 Vienna

Authors:

Y. XU1, M. zhang2, G. Xu2, X. Zou2

Created: Thursday, 30 January 2020, 10:12 AM
DOP68: Assessment of patients' understanding of Inflammatory Bowel Diseases (IBD): Development and validation of a questionnaire (U-IBDQ)
Year: 2021
Source: ECCO'21 Virtual
Authors: Ostromohov, G.(1);Fiebelman, M.(1,2);Hirsch, A.(1,3);Ron, Y.(1,3);Aviv Cohen , N.(1,3);Kariv , R.(1,3);Deutsch, L.(1,3);Anbar, R.(1,4);Maharshak, N.(3,5);Fliss Isakov, N.(1,6)
Created: Wednesday, 2 June 2021, 4:12 PM
DOP68: Autophagy induction in the intestinal epithelium protects against inflammation-induced barrier loss in vivo.
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Kushal Saha
Created: Friday, 14 July 2023, 2:22 PM
DOP68: Autophagy induction in the intestinal epithelium protects against inflammation-induced barrier loss in vivo.
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Saha, K.(1)*;Ganapathy, A.S.(1);Wang, A.(1);Morris, N.(1);Yochum, G.(2);Koltun, W.(2);Ding, W.(2);Nighot, M.(1);Ma, T.(1);Nighot, P.(1);
Created: Friday, 14 July 2023, 10:43 AM
DOP68: CD-TREAT diet induces remission and improves quality of life in an open label trial in children and adults with active Crohn’s Disease
Year: 2022
Source: ECCO'22
Authors: Svolos, V.(1);Hansen, R.(1);Russell, R.(1);Gaya, D.R.(1);John Paul, S.(1);Macdonald, J.(1);Nichols, B.(1);Papadopoulou, R.(1);Logan, M.(1);Mckirdy, S.(1);Gervais, R.(1);Ijaz, U.(1);Milling, S.(1);Shields, S.(1);Wilson, D.(1);Henderson, P.(1);Din, S.(1);Ho, G.T.(1);Gerasimidis, K.(1);
Created: Friday, 11 February 2022, 3:52 PM
DOP68: Histological remission (NANCY index) is superior to endoscopic mucosal healing in predicting relapse-free survival in patients with ulcerative colitis in clinical and endoscopic remission
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

H. Wang*1, I. Fewings2, L. Bornman1, B. Shadbolt3, M. Fadia2, K. Subramaniam1,4

Created: Friday, 22 February 2019, 9:41 AM
DOP68: Natural history of isolated Crohn's Disease perianal fistula
Year: 2024
Source: ECCO'24 Stockholm
Authors: Wong, Serre-Yu
Created: Tuesday, 30 April 2024, 5:03 PM
DOP69 Tofacitinib in ulcerative colitis: Early ‘real-world’ experience from four UK tertiary centres
Year: 2020
Source:

ECCO'20 Vienna

Authors:

D. Chee1, S. Honap2, T.P. Chapman3, A.J. Kent4, M. Patel4, B. Hayee4, P. Dubois4, L. Medcalf4, E. Sharma5, Y. Begum5, S. Ray2, J. Kennedy3, S. Cripps6, C. Elworthy7, A. Walsh3, J.R. Goodhand1, T. Ahmad1, J. Satsangi3, N.A. Kennedy1, P. Irving2, LEO (London, Exeter, Oxford) Consortium - Travis S, Brain O, Palmer R

Created: Thursday, 30 January 2020, 10:12 AM
DOP69: Glycans as an actor in the microbiome-immune response crosstalk.
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Salomé Pinho
Created: Friday, 14 July 2023, 2:22 PM